Delivery Order SPE2DB24D2003-SPE2DB25FXMA3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $6,877.85 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.11 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $16,036.57. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 19, 2025. The award represents pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMA3Delivery Order
The Defense Logistics Agency awarded a $2,702.70 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This firm fixed-price, non-set-aside contract is scheduled for completion by August 25, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract relationship with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026. This prime vendor contract enables the company to supply a comprehensive range of pharmaceuticals, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The current award reflects the company's ongoing role in fulfilling federal pharmaceutical supply requirements through competitively awarded, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/22/25 |